Overview
Fumihito Kasama practices practicing medicine in Akita, Japan.
Their clinical expertise encompasses Bone Tumor, Osteolysis Syndrome Recessive, Osteoporosis, and Vertebroplasty.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Fumihito Kasama
Is Fumihito Kasama a top-rated expert for Bone Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Fumihito Kasama is classified as an Experienced expert for Bone Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fumihito Kasama participate in research or clinical trials?
Yes. Fumihito Kasama has published 11 articles and abstracts on conditions like Bone Tumor. You can view a list of Fumihito Kasama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorKasama isExperienced. Learn about Bone Tumor.
- Osteolysis Syndrome RecessiveKasama isExperienced. Learn about Osteolysis Syndrome Recessive.
- OsteoporosisKasama isExperienced. Learn about Osteoporosis.
- VertebroplastyKasama isExperienced. Learn about Vertebroplasty.